🇮🇳IN
Sign In
PG

PGHL

NSE

Procter & Gamble Health Limited

₹5,513.50

+114.50(+2.12%)

Group Companies

Foreign Flows

sector level — not this stock
Healthcare sector+₹2,114 Crnet foreign buying
2026-09-01 to 2026-09-15

This is the flow into the whole Healthcare sector, not into PGHL. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.

Supply Chain

suppliers and customers in the graph

Relationship Network

directors, institutions, group entities

Macro Sensitivity

rates, currency, commodities

Revenue by Segment

Business Group

Geographic Exposure

revenue, imports, currency

Scenario analysis

stated assumptions, shown workings

PGHL exposure summary

Procter & Gamble Health Limited reports a single business segment, PHARMACEUTICALS. Procter & Gamble Health Limited is a constituent of 2 indices.

Index memberships2

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer